What COMPASS Pathways plc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 1 | 7 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 7 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Nath Kabir | Chief Executive Officer | Aug 03 | Withheld — tax / exercise cost · F | −5,962 | $11.25 | −$67.1K | 361,028 |
| Loxam Teri | Chief Financial Officer | Mar 26 | Grant / award · A | +75,000 | — | — | 152,002 |
| Nath Kabir | Chief Executive Officer | Mar 26 | Grant / award · A | +175,000 | — | — | 366,990 |
| Loxam Teri | Chief Financial Officer | Mar 11 | Withheld — tax / exercise cost · F | −1,781 | $6.89 | −$12.3K | 77,002 |
| Nath Kabir | Chief Executive Officer | Mar 11 | Withheld — tax / exercise cost · F | −13,131 | $6.89 | −$90.5K | 191,990 |
| Loxam Teri | Chief Financial Officer | Mar 02 | Withheld — tax / exercise cost · F | −4,467 | $7.02 | −$31.4K | 78,783 |
| Nath Kabir | Chief Executive Officer | Feb 02 | Withheld — tax / exercise cost · F | −16,181 | $6.61 | −$107K | 205,121 |
| Nath Kabir | Chief Executive Officer | Aug 01 | Withheld — tax / exercise cost · F | −6,366 | $4.34 | −$27.6K | 221,302 |
| Nath Kabir | Chief Executive Officer | Mar 11 | Grant / award · A | +92,000 | — | — | 227,668 |
| Loxam Teri | Chief Financial Officer | Mar 11 | Grant / award · A | +25,000 | — | — | 83,250 |
| Loxam Teri | Chief Financial Officer | Mar 03 | Withheld — tax / exercise cost · F | −4,468 | $3.67 | −$16.4K | 58,250 |
| Nath Kabir | Chief Executive Officer | Feb 03 | Withheld — tax / exercise cost · F | −15,516 | $4.31 | −$66.9K | 135,668 |
| Goldsmith George Jay | 10% owner | Oct 24 | Open-market sale · S | −776,565 | — | — | 3,152,848 |
| Goldsmith George Jay | 10% owner | Oct 24 | Open-market sale · S | −776,565 | — | — | 3,155,122 |
| Malievskaia Ekaterina | 10% owner | Oct 24 | Open-market sale · S | −776,565 | — | — | 3,155,122 |
| Malievskaia Ekaterina | 10% owner | Oct 24 | Open-market sale · S | −776,565 | — | — | 3,152,848 |
| Atai Life Sciences B.v. | 10% owner | Sep 26 | Open-market sale · S | −2,660,000 | $6.05 | −$16.1M | 6,905,774 |
| Nath Kabir | Chief Executive Officer | Aug 01 | Withheld — tax / exercise cost · F | −7,064 | $6.88 | −$48.6K | 151,184 |
| Jenkins Annalisa | Director | Aug 01 | Withheld — tax / exercise cost · F | −161 | $6.88 | −$1.11K | 19,480 |
| Goldsmith George Jay | 10% owner | May 21 | Disclosed 10b5-1 sale · S | −8,900 | $7.91 | −$70.4K | 3,929,413 |
Loading...